Cite
HARVARD Citation
Wang, Z. et al. (2022). 422.2: Investigating Galectin-3 as a Novel Therapeutic Target To Block Inflammation and Reduce Ischemia Reperfusion Injury During Vascular Composite Allograft Transplantation. Transplantation. p. S455. [Online].